M. Brinkhuis et al., INTRATUMOR HETEROGENEITY OF MORPHOMETRIC AND STEREOLOGIC VARIABLES INPRIMARY OVARIAN-TUMORS AND THEIR OMENTAL METASTATIC DEPOSITS, Analytical and quantitative cytology and histology, 19(3), 1997, pp. 185-193
OBJECTIVE: To compare quantitative pathologic variables assessed in pr
imary ovarian tumors and metastatic tumor deposits in the omentum and
compare their prognostic value. STUDY DESIGN: In 29 cases of advanced
ovarian cancer the mean nuclear area (MNA), volume-weighted mean nucle
ar volume ((v) over bar)(v), volume percentage epithelium (VPE) and mi
totic activity index (MAI) were assessed in both the primary ovarian t
umor and its metastatic deposits in the omentum. Differences were eval
uated using the Wilcoxon rank sum test for paired observations, and co
efficients of variation were calculated in each case over the values o
btained from the tumor in the ovary and omentum. RESULTS: Intraobserve
r and interobserver reproducibility of MNA, VPE and MAI were all good
to very good except for the interobserver reproducibility for (v) over
bar(v) which was moderate. MNA and (v) over bar(v), correlated well,
both in the primary ovarian tumor (r=.88) and omental metastasis (r=.8
7). No significant differences were found between the assessments of M
NA, (v) over bar(v), and MAI in the primary ovarian tumor and its omen
tal metastasis, whereas significant differences were found for VPE. Ho
wever, in some patients the nuclei tended to be larger and the VPE low
er in the omental metastasis than irt the primary ovarian tun?or. No i
mportant impact of the origin of tumor tissue was reflected in the pro
gnostic value of the nuclear features. Patients were grouped prognosti
cally differently for the assessment of MAI and VPE in the primary ova
rian tumor and its omental metastasis. CONCLUSION: Quantitative pathol
ogic variables for prognostic purposes are best assessed in the primar
y ovarian tumor. Measurements in the metastatic deposits may be helpfu
l in understanding processes of metastasis in advanced ovarian cancer.